LODINE

This brand name is authorized in France, Turkey, United Kingdom

Active ingredients

The drug LODINE contains one active pharmaceutical ingredient (API):

1 Etodolac UNII 2M36281008 - ETODOLAC

Etodolac is a non-steroidal anti-inflammatory drug (NSAID). Studies in-vitro and in human cell models have confirmed that etodolac is selective for the inhibition of COX-2. Experiments have shown etodolac to have marked anti-inflammatory activity, being more potent than several clinically established NSAIDs.

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LODINE SR Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M01AB08	Etodolac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 68032346, 68645185
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 26093
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699033090014, 8699033090021, 8699033090427